In the early months of the COVID-19 pandemic, UC San Francisco researchers were already seeing signs of lingering symptoms in some who had been infected. Importantly, this was when experts still ...
You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...
In this article, Dr. Luis J. Montaner answers questions about how HIV works, the probability of finding a cure and what it’s like collaborating with local communities on HIV research. By Dr. Luis J.
The human immunodeficiency virus (HIV), which is the cause of AIDS, is a master of deception, using just nine genes to hijack the complex cellular machinery of the human body. Yet, even after decades ...
The first ever injectable drug that can prevent HIV has been approved for use in England and Wales. The drug, cabotegravir, would benefit an estimated 1,000 people at risk of HIV in England and Wales.
University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure: Their research shows that small changes in the virus affect how quickly or slowly ...
University of Virginia School of Medicine scientists have uncovered a key reason why HIV remains so difficult to cure, bringing researchers closer to finding ways to flush out the dormant virus and ...
Is a cure for HIV in sight? Since the virus that causes AIDS was identified over 40 years ago, finding a cure has been the holy grail of HIV research and the army of scientists conducting it. While ...
The first ever injectable drug that can prevent HIV has been approved for use in England and Wales. The drug, cabotegravir, would benefit an estimated 1,000 people at risk of HIV in England and Wales.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results